424 related articles for article (PubMed ID: 18640262)
1. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
[TBL] [Abstract][Full Text] [Related]
4. Teratogenic risk of statins in pregnancy.
Godfrey LM; Erramouspe J; Cleveland KW
Ann Pharmacother; 2012 Oct; 46(10):1419-24. PubMed ID: 23032657
[TBL] [Abstract][Full Text] [Related]
5. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.
Boskovic R; Wide R; Wolpin J; Bauer DJ; Koren G
Neurology; 2005 Sep; 65(6):807-11. PubMed ID: 16186517
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome following in utero exposure to bisphosphonates.
Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
10. Risk of birth defects associated with nelfinavir exposure during pregnancy.
Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome of women exposed to azathioprine during pregnancy.
Goldstein LH; Dolinsky G; Greenberg R; Schaefer C; Cohen-Kerem R; Diav-Citrin O; Malm H; Reuvers-Lodewijks ME; Rost van Tonningen-van Driel MM; Arnon J; Ornoy A; Clementi M; Di Gianantonio E; Koren G; Braunstein R; Berkovitch M
Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):696-701. PubMed ID: 17847119
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome after in utero exposure to colchicine.
Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
14. Fetal outcome after technetium scintigraphy in early pregnancy.
Schaefer C; Meister R; Wentzeck R; Weber-Schoendorfer C
Reprod Toxicol; 2009 Sep; 28(2):161-6. PubMed ID: 19442716
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
17. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
18. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
19. Statins: beware during pregnancy.
Prescrire Int; 2006 Feb; 15(81):18-9. PubMed ID: 16548110
[TBL] [Abstract][Full Text] [Related]
20. A study of the teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempts by pregnant women.
Timmermann G; Czeizel AE; Bánhidy F; Acs N
Toxicol Ind Health; 2008; 24(1-2):109-19. PubMed ID: 18818187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
